Search - tctmd.com

Displaying 241 - 260 of 268

Sort: Relevancy | Date

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Conference News EuroPCR 2015

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Yael L. Maxwell

May 20, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

April 10, 2015

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

March 20, 2015

News Daily News

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

February 19, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

January 12, 2015

News Daily News

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

December 16, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

July 17, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

March 31, 2014

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

November 16, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.